Patients with nonsevere COVID may avoid progression to hospitalization or death through treatment with nirmatrelvir-ritonavir or molnupiravir, according to a systematic review and meta-analysis.
Pitre and colleagues extracted data from randomized trials that compared antiviral therapies with placebo or standard care from the Epistemonikos COVID-19 L·OVE database through April 25, 2022. Forty-one trials involving 18,568 patients with nonsevere COVID-19 were included in the analysis. Participants' ages ranged between 36 and 65 years, and about half of participants were men.
Hospitalization risk was reduced with nirmatrelvir-ritonavir , compared with standard care or placebo. Molnupiravir probably reduced the risk , and remdesivir may have reduced the risk . "Adaptive platform trials and large observational studies offer the best opportunities to generate timely evidence on the effectiveness of COVID-19 therapeutics," write Corinne Hohl, MD, MHSc, associate professor of emergency medicine at University of British Columbia, Vancouver, and Andrew McRae, MD, PhD, assistant professor of emergency medicine at University of Calgary, Alberta, in an.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Reformulated COVID vaccine boosters may be available earlier than expectedThe Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant. | via NPR
Baca lebih lajut »
Reformulated COVID vaccine boosters may be available earlier than expectedThe Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.
Baca lebih lajut »
More cities may bring back mask mandates as COVID cases rise'We're asking you to take a sensible step, when there's this much transmission with a highly transmissible variant, to go ahead and put back on a well-fitting high-filtration mask when you're indoors around others.'
Baca lebih lajut »
Immune Response May Explain Brain Damage After COVID-19In response to SARS-CoV-2 infection, the body produces antibodies that damage the cells lining the brain's blood vessels, leading to inflammation and impairment.
Baca lebih lajut »
Businesses may consider mask policies as COVID-19 cases increaseWhile the state health department explained any statewide masks polices are unlikely, many Alabama retailers and businesses are exercising the freedom to enforce their own masking policies as COVID-19 cases spike across the state.
Baca lebih lajut »
COVID Virus May Tunnel through Nanotubes from Nose to BrainNanotubes may provide a cunning answer to the mystery of how the virus that causes COVID infects neurons and produces long-lasting neurological symptoms
Baca lebih lajut »